NET INCOME (LOSS) PER SHARE (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Earnings Per Share, Basic and Diluted

The following table summarizes the Company’s computation of basic and diluted net income (loss) per share available to common stockholders for the three months ended March 31, 2026 and 2025:


	Three Months Ended March 31,
	2026		2025
Numerator:
Net income (loss)	$	5,686	$	(5,688)
Less: Earnings allocated to participating securities
Accumulated undeclared dividends - Series A	(2,664)		—
Accumulated undeclared dividends - Series B	(2,283)		—
Allocable net income (loss)	739		(5,688)
Allocation of undistributed earnings - Series A	(199)		—
Allocation of undistributed earnings - Series B	(185)		—


Net income (loss) available to common stockholders	$	355	$	(5,688)
Denominator:

Weighted average common shares outstanding - basic and diluted	5,455		4,618



Net income (loss) per common share available to common stockholders - basic and diluted	$	0.07	$	(1.23)

Schedule of Antidilutive Securities

The following table summarizes potential common shares outstanding at each period end that were excluded from diluted net income (loss) per share because their effect would have been anti-dilutive:


	Three Months Ended March 31,
	2026	2025
Public warrants	500,000	500,000
Private warrants	13,300	13,300
Stock options	255,189	270,554
Unvested restricted stock units	83,396	203,714
Shares issuable upon Series A and Series B Preferred Stock Conversion	5,891,471	—
Total potential common shares excluded	6,743,356	987,568